These results are in agreement with a previous study in the CCl4 mouse model of hepatic fibrosis, where it was found that three BET inhibitors—I-BET151, JQ1, and PFI-1—all decreased pro-fibrotic gene expression in the presence and absence of TGF-β118. This evidence concerns the gene DNER and Hepatic fibrosis.